BPC 157: A MAHA Adjacent Peptide, Linked to Croatia BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Everything You Need to Know About the FDA Peptide Ban FDA Peptide Update 2026: Major Changes in Medicine TikTok When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA takes first step in possible reversal of ban on some peptides The Washington Post